408 related articles for article (PubMed ID: 32351288)
1. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
[TBL] [Abstract][Full Text] [Related]
6. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
[TBL] [Abstract][Full Text] [Related]
8. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
9. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.
Yan L; Dong X; Gao J; Liu F; Zhou L; Sun Y; Zhao X
Cancer Med; 2018 May; 7(5):1802-1813. PubMed ID: 29577639
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma.
Chang C; Wang MJ; Bi XF; Fan ZY; Feng D; Cai HQ; Zhang Y; Xu X; Cai Y; Qi J; Wei WQ; Hao JJ; Wang MR
J Clin Lab Anal; 2021 Sep; 35(9):e23904. PubMed ID: 34288108
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
Chen J; Chen M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1048-1053. PubMed ID: 30523223
[TBL] [Abstract][Full Text] [Related]
12. Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances.
Mou X; Peng Z; Yin T; Sun X
J Gastrointest Cancer; 2024 Mar; 55(1):118-128. PubMed ID: 37924487
[TBL] [Abstract][Full Text] [Related]
13. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
14. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
Wang M; Liu F; Pan Y; Xu R; Li F; Liu A; Yang H; Duan L; Shen L; Wu Q; Liu Y; Liu M; Liu Z; Hu Z; Chen H; Cai H; He Z; Ke Y
EBioMedicine; 2021 Nov; 73():103674. PubMed ID: 34753106
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
[TBL] [Abstract][Full Text] [Related]
17. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions.
Wang M; Smith JS; Wei WQ
Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970
[TBL] [Abstract][Full Text] [Related]
18. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning.
Yuan Y; Zhao Z; Xue L; Wang G; Song H; Pang R; Zhou J; Luo J; Song Y; Yin Y
Br J Cancer; 2021 Aug; 125(3):351-357. PubMed ID: 33953345
[TBL] [Abstract][Full Text] [Related]
19. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
[TBL] [Abstract][Full Text] [Related]
20. Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: A case-cohort study in Japan.
Aversa J; Song M; Shimazu T; Inoue M; Charvat H; Yamaji T; Sawada N; Pfeiffer RM; Karimi P; Dawsey SM; Rabkin CS; Tsugane S; Camargo MC
Int J Cancer; 2020 Aug; 147(3):686-691. PubMed ID: 31671219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
